Clinical Research Acceleration

Challenge: Traditional clinical trials are expensive, slow, and often fail to recruit representative participants.

DeMedic Solution: Researchers can tap into permissioned, real-world datasets from diverse populations, accelerating study design, cohort selection, and data collection. With patient consent embedded in smart contracts, the process is faster, cheaper, and ethically compliant.

Example: A biotech firm studying rare autoimmune diseases can use DeMedic to request longitudinal data from verified patients worldwide—without relying on centralized hospitals.